O3 Bone scan index as a biomarker to predict outcome in mCRPC patients on abiraterone acetate (Zytiga™) – a multicenter study

Date 15 November 2014
Event EMUC 2014
Session Oral presentations of the best abstracts
Topics Anti-Cancer Agents & Biologic Therapy
Prostate Cancer
Imaging, Diagnosis and Staging
Presenter M. Reza